KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR)

Target's Q2 2026 earnings release is set for August 19, 2026; low importance is estimated as the date announcement itself typically has a market impact of less than 5%, scheduled.

The U.S. FDA set a PDUFA target action date for iberdomide on 2026-08-17; importance is Low as the setting of a PDUFA date is a procedural event with minor price impact.

Q2 2026 earnings release and conference call for August 10, 2026, which is expected to have a medium impact by providing key financial updates, scheduled.

Q2 2026 earnings release is scheduled for August 7, 2026; analysts forecast a significant increase in earnings due to higher oil prices and full integration of Hess assets. Market impact is estimated at Medium (5%) as earnings are a primary driver of stock volatility, scheduled.

Q2 2026 earnings release scheduled for 2026-08-06. Analysts forecast EPS of around $1.60 forecasted. High importance estimated due to the 26% price movement in the previous earnings release scheduled.

Q2 2026 earnings release on 2026-08-06 is scheduled. Low importance is estimated as the primary market impact occurs on the release date, scheduled.

Q2 2026 earnings release is scheduled.

Next quarterly earnings for Q1 2027 are expected to be released around August 6, 2026, expected. Low impact is estimated as this is a routine scheduling announcement.

FDA Prescription Drug User Fee Act (PDUFA) target action date for its seasonal flu vaccine (mRNA-1010) on August 5, 2026; Medium importance as PDUFA dates are major catalysts for biotech stocks, scheduled.

AppLovin's Q2 2026 earnings release is expected around August 5, 2026, based on past reporting schedules expected. Low impact estimated as the announcement of a date typically precedes the actual market-moving results.

Q2 2026 earnings release, with a price impact of 1% or more expected, is scheduled.

Q2 2026 earnings release is scheduled for August 5, 2026.

Q2 2026 earnings release and conference call scheduled.

Q2 2026 earnings release on 2026-08-04, for which high importance is estimated due to potential 10% price impact, is scheduled.

Next quarterly earnings for Q2 2026 are expected to be announced on August 4, 2026; medium impact estimated based on historical volatility during earnings releases, expected.

Next earnings release for Q2 2026 is estimated to be on or around August 4, 2026, based on past reporting schedules, estimated.

Q2 2026 earnings release and conference call scheduled.

ON Semiconductor is expected to announce its Q2 2026 earnings on or around August 3, 2026. Analysts forecast EPS of $0.72, which would be a year-over-year increase of 35.85% forecasted.

Next earnings release for Q2 2026 on 2026-08-03 expected.

Q2 2026 earnings release is scheduled.

High importance as quarterly earnings releases typically result in significant price volatility; Q2 2026 earnings release for 2026-07-30 scheduled, for which analysts forecast EPS of $1.02 forecasted.

Q2 2026 earnings release is scheduled.

Second quarter 2026 earnings release scheduled; medium impact expected as a key financial update.

Comcast's Q2 2026 earnings release on July 30, 2026 scheduled. Medium importance is estimated as earnings reports often impact stock prices.

Fiscal Q4 2026 earnings release on July 30, 2026, is expected to have a medium importance impact on the stock price, scheduled.

Apple's Q3 2026 earnings release is expected on July 30, 2026; analysts forecast an EPS of approximately $1.86 forecasted. Low importance is estimated as the market impact is expected to be around 1%.

Q2 2026 earnings release for 2026-07-30. Low importance as it is a routine announcement scheduled.

Bristol-Myers Squibb Q2 2026 earnings release on 2026-07-30 scheduled; importance is Low as the announcement of an earnings date typically has a <5% price impact.

Next quarterly earnings report for Q2 2026 is scheduled.

Mastercard's Q2 2026 earnings release is scheduled.

Second quarter 2026 earnings release and conference call scheduled. The announcement is expected to result in a ≥1% price impact, scheduled.

Southern Company is scheduled to report its Q2 2026 earnings results on July 30, 2026, scheduled. Low importance is estimated as the announcement of the date itself typically has minimal immediate price impact.

Q3 2026 earnings release and conference call scheduled. Estimated > 10% impact as quarterly earnings are primary volatility drivers.

Q2 2026 earnings release with guidance of $8.1-$8.2 billion sales and $1.14-$1.16 adjusted EPS, which typically drives significant price volatility, scheduled.

Microsoft's fiscal Q4 2026 earnings release and conference call are scheduled for July 29, 2026. Analysts forecast earnings of $4.21-$4.23 per share, which is estimated to have a 5% price impact based on historical volatility forecasted.

Q4 and full fiscal year 2026 earnings results scheduled; estimated 5% price impact based on historical earnings volatility, scheduled.

Q2 2026 earnings release, with an estimated 1% or more price impact, is scheduled.

Q2 2026 earnings release on July 29, 2026; impact is estimated as Low as this is a standard scheduled announcement, expected.

Low importance is estimated for the next Entegris earnings report on July 29, 2026, as it is a routine announcement that is scheduled.

IQVIA Holdings is scheduled to announce its second-quarter 2026 financial results before the market opens on or around 2026-07-28, based on past reporting schedules. High importance is estimated as earnings releases typically cause significant price movement, scheduled.

Q2 2026 earnings release and conference call scheduled. Importance is estimated as Medium, as earnings reports for growth companies often lead to significant price volatility.

Alphabet's Q2 2026 earnings release is scheduled.

Q2 2026 earnings release is scheduled for July 28, 2026. Analysts forecast EPS of approximately $0.93. Low impact is anticipated as the event has not yet occurred scheduled.

Q2 2026 earnings release expected; high importance due to potential for significant price movement following the report expected.

Second-quarter 2026 earnings results and conference call scheduled for 2026-07-24. Quarterly earnings releases are estimated to cause a price impact of at least 5%, scheduled.

Q2 2026 earnings release on 2026-07-23 is scheduled. Market impact is estimated at 5% based on historical volatility around quarterly earnings announcements.

Q2 2026 earnings release is scheduled. Medium importance estimated as quarterly results typically drive significant price volatility; scheduled.

Estimated Low importance as results are not yet known; Q2 2026 earnings release on 2026-07-23 scheduled.

Q2 2026 earnings release, with an estimated price impact of at least 1% based on historical volatility, scheduled.

Release of Q2 2026 financial results and conference call, for which high importance is estimated due to typical earnings-related market volatility, is scheduled.

Texas Instruments Q2 2026 earnings release on 2026-07-22. The company forecasted revenue between $5.0B and $5.4B and EPS between $1.77 and $2.05. High importance estimated due to typical earnings volatility scheduled

GE Vernova Q2 2026 earnings release and webcast scheduled for 2026-07-22. This event is expected to have a medium price impact of at least 5% scheduled.

Earnings releases typically result in significant price volatility of at least 5%, so Lennox International will release its Q2 2026 earnings results around July 22, 2026, based on past reporting schedules expected.

Tesla's Q2 2026 earnings release is scheduled for July 22, 2026. Analysts forecast an EPS of approximately $0.42 to $0.45. A medium impact is estimated based on historical volatility, forecasted.

Q2 2026 earnings release on July 22, 2026 expected

Q2 2026 earnings release is scheduled for 2026-07-22, with analysts forecasting EPS of approximately $0.49. This scheduled release is estimated to have a low price impact (>=1%), expected.

Q2 2026 earnings release is scheduled for 2026-07-22; analysts forecast EPS of $2.95, with a neutral impact estimated as the forecast is already public forecasted.

Q2 2026 earnings release on July 22, 2026. Low importance estimated as no market reaction has occurred yet; event is expected.

Q2 2026 earnings release is scheduled. Analysts forecast EPS to be between $1.77 and $1.90 forecasted. Low importance is estimated based on typical earnings volatility, and the release is scheduled.

Intuitive Surgical's Q2 2026 earnings release, a major stock catalyst, is scheduled.

Regions Financial is scheduled to announce its Q2 2026 financial results on July 17, 2026, before the market opens. Earnings releases typically cause significant volatility, justifying a Medium importance estimate. This is a scheduled event.

Truist Financial's second quarter 2026 earnings release is scheduled for July 17, 2026. Market impact is estimated at 1-3% based on historical volatility scheduled.

Netflix's Q2 2026 earnings release is scheduled for 2026-07-16. Analysts forecast EPS of $0.79 on revenue of $12.57 billion; High importance assigned based on historical earnings volatility often exceeding 10%, forecasted.

State Street Corporation is scheduled to announce its second-quarter 2026 financial results on July 16, 2026, before the market opens, with a conference call at 11:00 a.m. ET; high importance is estimated based on the potential for a price impact of 10% or more, scheduled.

Abbott's Q2 2026 earnings release is scheduled for July 16, 2026. Analysts forecast EPS of $1.28. Medium importance estimated as earnings typically drive >5% price movement expected.

PepsiCo is scheduled to release its Q2 2026 financial results. Analysts' consensus forecast is for an EPS of approximately $2.22, scheduled. Medium importance is estimated as earnings releases typically impact stock prices by 5% or more.

Low importance estimated as earnings releases typically drive at least 1% price movement; GE Aerospace Q2 2026 earnings release and webcast on 2026-07-16 scheduled.

Charles Schwab is expected to announce its Q2 2026 earnings results around mid-July, with analysts forecasting an EPS of approximately $1.49-$1.50. The specific date is estimated to be July 16, 2026, but is not yet confirmed. Market impact is estimated to be low until the actual release. expected

J.B. Hunt is expected to announce its Q2 2026 earnings results around this date, based on historical reporting schedules. Earnings releases typically cause significant price movement, so a medium impact is scheduled

Q2 2026 earnings results and conference call scheduled.

Johnson & Johnson Q2 2026 earnings release and conference call, with low impact estimated as a routine event, scheduled.

Q2 2026 earnings release is scheduled.

Q2 2026 earnings release and conference call scheduled.

Citigroup's second-quarter 2026 earnings release is scheduled for July 14, 2026. High market impact is expected based on historical volatility around earnings reports, scheduled.

Bank of America's Q2 2026 earnings release is scheduled for 2026-07-14. Low impact is estimated as the market typically anticipates scheduled earnings dates.

Q2 2026 earnings release scheduled.

Ex-dividend date on 2026-07-10 for a quarterly cash dividend of $0.52 per share payable on 2026-07-29; low importance estimated due to minor price impact; scheduled.

Q2 2026 earnings release on 2026-07-09. Analysts forecast EPS around $1.49-$1.51, while the company guided for EPS between $1.00 and $1.50; scheduled.

The ex-dividend date for an increased quarterly cash dividend of $0.55 per share, raised from $0.54. The dividend was announced on April 17, 2026, with the ex-date set for July 2, 2026 scheduled. Low importance as dividend increases are standard corporate actions.

Comcast declared a quarterly dividend of $0.33 per share. The ex-dividend date is July 1, 2026, with the payment date set for July 22, 2026.

NIKE, Inc. plans to release its fourth quarter fiscal 2026 financial results after the market closes on June 30, 2026, followed by a conference call with management. This release will cover the full fiscal year performance and provide future guidance. High importance is estimated as earnings releases typically cause significant price volatility, scheduled.

Ex-dividend date for the Q2 2026 dividend of $1.61 per share, payable on July 10, 2026 scheduled. Low impact estimated as it is a routine dividend.

The ex-dividend date (2026-06-30) for a regular quarterly dividend of $0.50 per share, declared on May 20, 2026, is scheduled. This event is estimated to have a price impact of at least 1% scheduled.

Ex-dividend date for a Q2 2026 regular cash dividend of $0.05 per share, payable on July 15, 2026.

Honeywell is scheduled to spin off its Aerospace division into a new, independent, publicly traded company called Honeywell Aerospace (ticker: HONA) on 2026-06-29. The remaining company will be rebranded as Honeywell Technologies (ticker: HON), a major corporate restructuring event expected to significantly impact shareholder value and company focus scheduled.

Darden Restaurants plans to release its fiscal 2026 fourth quarter and full year financial results before the market opens on June 25, 2026, scheduled. High importance is estimated as annual earnings reports typically result in significant price volatility exceeding 10%.

Quarterly dividend of $0.6575 per share scheduled, with an ex-dividend date of June 25, 2026. Low importance is estimated as the dividend typically results in a price adjustment of approximately 1% on the ex-dividend date, scheduled.

Micron Technology fiscal third-quarter 2026 financial results announcement scheduled. High importance expected due to historical price volatility of over 10% following earnings releases expected.

As a recurring major financial disclosure, this event has the potential for a significant market reaction; Q4 fiscal year 2026 earnings release is scheduled.

Investor Day 2026 in New York City to outline growth and diversification strategy with a focus on AI scheduled. Estimated > 1% impact as it provides long-term strategic clarity.

Analysts forecast EPS of approximately $0.34 forecasted. High importance due to potential for significant volatility following the recent corporate restructuring. Q2 2026 earnings release scheduled for 2026-06-23 expected.

Ex-dividend date for a quarterly cash dividend of $0.25 per share on June 23, 2026, which typically results in minor price adjustments, scheduled.

Quarterly dividend of $0.26 per share, announced on May 21, 2026, goes ex-dividend on June 17, 2026.

Annual Meeting of Stockholders scheduled.

Jabil Q3 FY2026 earnings release on 2026-06-16; analysts forecast continued growth driven by AI infrastructure demand forecasted. Medium impact estimated as earnings releases typically drive significant price movement, scheduled.

Mastercard's 2026 Annual Stockholder Meeting is scheduled.

Launch of three BlueBird satellites (8, 9, and 10) via a SpaceX Falcon 9 rocket on June 15, 2026, which is expected to have a medium impact as a significant deployment milestone, scheduled.

Ex-dividend date of 2026-06-15 for the quarterly dividend of $0.26 per share, following an 8% increase announced on 2026-05-14; a price impact of 1% or more is expected.

Ex-dividend date for a quarterly cash dividend of $1.22 per share on 2026-06-15, originally announced on May 12, 2026. Market impact is estimated at 1% as the stock price typically adjusts by the dividend amount.

Leidos will go ex-dividend for its quarterly payout of $0.43 per share on June 15, 2026, scheduled to be paid on June 30, 2026.

Meta's quarterly cash dividend of $0.525 per share has an ex-dividend date of June 15, 2026; a price impact of ≥1% is expected.

KLA Corporation confirmed a 10-for-1 forward stock split of its common shares. Shareholders of record on 2026-06-04 receive nine additional shares after the close on 2026-06-11, and KLAC begins trading on a split-adjusted basis on 2026-06-12.

The ex-dividend date for a regular quarterly cash dividend of $1.70 per share on June 12, 2026. The dividend was declared on April 8, 2026, and is payable on July 1, 2026. Market impact is expected to be low as this is a routine corporate action, scheduled.

The ex-dividend date for the quarterly cash dividend of $0.525 per share is on June 12, 2026. The dividend is payable on June 29, 2026, with low impact expected from this regular distribution, scheduled.

Adobe is scheduled to release its Q2 fiscal year 2026 earnings results after the market closes on June 11, 2026. Analysts forecast non-GAAP EPS of $5.01, which is below the company's prior guidance of $5.80 to $5.85, creating uncertainty ahead of the release. High importance is estimated based on potential market reaction to the guidance discrepancy, scheduled.

Oracle is scheduled to release its fourth quarter and full fiscal year 2026 financial results after the market close on June 10, 2026, with a conference call to follow. High importance is estimated as earnings releases typically result in significant price volatility, scheduled.

A virtual annual shareholder meeting is scheduled for 2026-06-10; approximately 1% price impact scheduled.

Comcast's Annual General Meeting on June 10, 2026 scheduled. Low importance is estimated as AGMs typically result in minimal price movement.

Quarterly dividend ex-date of $0.80 per share. The dividend is scheduled to be paid on July 9, 2026.

Quarterly dividend of $0.26 per share, with an ex-dividend date of June 10, 2026.

Cloudflare is scheduled to host its 2026 Investor Day at the New York Stock Exchange to provide updates on strategy and financials. This event is estimated to have a 5% price impact as strategic roadmaps are revealed, scheduled.

Company management will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on 2026-06-09. Low importance as conference participation typically has minimal immediate price impact scheduled.

CFO Gonzalo Luchetti is scheduled to present at the Morgan Stanley U.S. Financials Conference on June 9, 2026. Minor price impact is expected from this routine update, scheduled.

Quarterly cash dividend of $1.30 per share, with an ex-dividend date of June 9, 2026 and a payment date of June 25, 2026.

Regions Financial is scheduled to participate in the Morgan Stanley U.S. Financials Conference on June 9, 2026. Conference participation usually has a minor impact on stock price, justifying a Low importance estimate. This is a scheduled event.

Apple's Worldwide Developers Conference (WWDC) is scheduled for June 8-12, 2026, featuring major AI strategy announcements and new operating system previews, scheduled. High importance is estimated due to the anticipated impact of the AI strategy overhaul.

Ex-dividend date for a quarterly cash dividend of $0.22 per share, a 5% increase from the prior quarter. The dividend was declared by the Board of Directors on April 27, 2026.

Honeywell is scheduled to host a guidance update call on 2026-06-08 to discuss its 2026 outlook and introduce a preliminary full-year 2026 outlook for Honeywell Technologies scheduled.

Ex-dividend date for the declared Q2 2026 quarterly cash dividend of $0.67 per share. The dividend is payable on or before June 30, 2026, to shareholders of record on June 9, 2026.

CEO Albert Bourla is scheduled to speak at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026; low impact estimated as conference presentations typically result in minor price fluctuations, scheduled.

Announced on May 27, 2026, the redemption of $1.5 billion principal amount of its fixed-to-floating rate senior notes, originally due June 2027, effective June 8, 2026. Market impact is estimated at 1% as a routine financial adjustment scheduled.

Ex-dividend date (2026-06-05) for the Q2 2026 cash dividend of $0.28 per share. The dividend is payable on June 26, 2026.

Quarterly cash dividend of $0.27 per common share is payable on 2026-06-05 scheduled.

A quarterly dividend of $1.19 per share is payable on 2026-06-05 to shareholders of record as of 2026-05-15 scheduled.

Estimated Low importance as a routine action; quarterly dividend of $1.25 per share, ex-dividend date on 2026-06-05, scheduled.

Quarterly dividend of $0.6232 per share, with an ex-dividend date of June 5, 2026.

Quarterly cash dividend of $0.945 per share has an ex-dividend date of June 5, 2026. The dividend is payable on June 18, 2026. This event is expected to cause a 1% price impact, scheduled.

Ciena is scheduled to report its fiscal second quarter 2026 financial results on June 4, 2026, before the market opens. Analysts forecast EPS of $1.45-$1.46 on revenue of $1.50 billion. High importance is estimated as AI-related earnings often trigger >=10% price movement, scheduled.

Quarterly dividend of $1.56 per share with an ex-dividend date of 2026-06-04 expected; low impact expected from routine dividend.

Quarterly dividend of $2.33 per share, ex-dividend date on 2026-06-04.

Annual Meeting of Stockholders is scheduled for 2026-06-04; Low importance assigned as typical price impact is expected to be at least 1%, scheduled.

Ex-dividend date for the increased quarterly cash dividend of $0.92 per share, payable on June 25, 2026, scheduled for June 4, 2026. Estimated > 1% impact as the dividend amount is significant.

2026 Annual Shareholders' Meeting on 2026-06-04 scheduled.

Broadcom is scheduled to release its Q2 2026 earnings results after the market closes on June 3, 2026. Analysts forecast revenue of approximately $22.1 billion and EPS of $2.40, with AI-related revenue expected to be a key focus; high importance is estimated due to historical earnings volatility exceeding 10%, scheduled.

First quarter fiscal year 2027 financial results to be released after market close on June 3, 2026, scheduled. High importance is estimated due to expected significant price movement following the report.

CEO Anirudh Devgan is scheduled to present at the Bank of America (BofA) Securities 2026 Global Technology Conference; low importance due to typically minimal market reaction to such presentations scheduled.

Costco's May 2026 monthly sales report release on June 3, 2026, with an internal analysis estimated <5% price impact, scheduled.

Trading for two Goldman Sachs bond ETFs will cease after market close on June 3, 2026, following a liquidation announcement; neutral impact from small fund size expected.

Company executives are scheduled to present at the Evercore Global TMT Conference on June 3, 2026, scheduled. Low impact is estimated as conference presentations typically provide incremental information.

Quarterly cash dividend of $0.25 per share with an ex-dividend date of June 3, 2026, declared on May 12, 2026, and payable on June 12, 2026.

Ex-dividend date on 2026-06-03 for the quarterly cash dividend of $0.295 per share, announced on April 24, 2026.

U.S. energy regulators granted a waiver to expedite the restart of the Three Mile Island nuclear power plant, which the company aims to bring back online by 2027 to power data centers.

Alphabet announced on June 1/2, 2026, a plan to raise up to $80 billion via stock offerings to fund AI infrastructure investments, citing that customer demand is exceeding its available compute supply. The plan includes a $10 billion private placement to Berkshire Hathaway.

IBM announced plans to invest more than $10 billion in quantum computing over the next five years, covering R&D, manufacturing, M&A, and partnerships to accelerate its quantum roadmap.

CEO Matt Murphy delivered a keynote at COMPUTEX 2026. During the event, NVIDIA CEO Jensen Huang referred to Marvell as the 'next trillion-dollar company,' causing the stock to surge over 20%.

Reported fiscal Q3 2026 earnings with non-GAAP EPS of $0.85, beating estimates, and revenue of $3.0 billion, a 31% year-over-year increase. The company guided for Q4 revenue between $3.345 billion and $3.355 billion. The stock rose over 10% in after-hours trading following the announcement.

Announced an expanded collaboration with NVIDIA on 2026-06-02 to integrate its Guardicore Segmentation security solution with NVIDIA's BlueField-4 STX architecture, aiming to embed Zero Trust security into AI factories.

Arista's CFO presented at the William Blair 46th Annual Growth Stock Conference, reiterating the company's strong outlook, including its $11.5 billion revenue guidance for 2026 and a raised long-term growth forecast (CAGR) to over 20% for 2025-2028.

Blackstone announced the final close of its largest-ever Asia private equity fund at $13.1 billion on 2026-06-02, exceeding its $10 billion target. This is estimated to have a medium impact due to significant AUM growth and increased future fee revenue.

CME Group reported record May 2026 average daily volume (ADV) of 33.2 million contracts, a 15% increase year-over-year, driven by strong growth in interest rate and equity index products.

CrowdStrike and Cognizant announced an expanded strategic alliance to secure artificial intelligence across its lifecycle. Medium importance is estimated based on the potential for long-term revenue growth from AI security.

The Phase 3 IDEAL study of Livdelzi (seladelpar) met its primary endpoint on June 2, 2026. This clinical success is estimated to have a ≥5% price impact, scheduled.

Mastercard announced a series of executive leadership changes effective August 3, 2026. Ling Hai will become the new CFO, succeeding Sachin Mehra who will become Chief Business Officer. The stock declined following the announcement.

At its Build 2026 conference on June 2, 2026, Microsoft is scheduled to announce new AI models and the Majorana 2 quantum chip, which is estimated to have a 5% price impact due to major technological advancements scheduled.

Stock price fell 8% on June 2, 2026, following new product and partnership announcements at the company's annual Snowflake Summit event.

Announced on 2026-06-02 that Julie Knecht will be appointed as the new Chief Financial Officer, effective August 1, 2026, succeeding the retiring CFO Rafael Lizardi.

Uber announced plans for its first commercial robotaxi pilot in Madrid, Spain, in partnership with WeRide, expanding its autonomous vehicle initiatives in Europe.

Workday shares dropped 8% on June 2, 2026, following the announcement of new AI product enhancements and partnerships at its DevCon event, including an integration with Amazon Web Services (AWS).

European Commission approved AQUIPTA (atogepant) for acute migraine treatment on 2026-06-02. Low importance as label expansions typically result in moderate price movement.

Comcast announced the pricing terms for its cash tender offer to purchase certain outstanding notes, part of a debt management strategy. The offer, which commenced May 27, 2026, expired on June 2, 2026.

Announced the launch of its investing and trading platform in India on June 2, 2026, providing users with direct access to the global crypto market via INR rails.

At its Cisco Live 2026 event on June 2, 2026, the company launched a suite of new AI-focused products and platforms, including Cisco Cloud Control and new AI security tools.

Mizuho analysts downgraded the stock from 'Outperform' to 'Neutral' and lowered the price target to $105 from $118 on 2026-06-02, estimated.

Meta announced the global expansion of teen safety settings on June 2, 2026; a price impact of ≥1% is expected.

Russia's Federal Security Service (FSB) accused Cloudflare of involvement in a cyber operation to spy on officials. This event is estimated to have a 1% price impact as geopolitical tensions have limited effect on tech stocks.

Wolfe Research analysts forecast an 'Outperform' rating and a $260 price target on 2026-06-02 estimated.

Announced the pricing of a secondary offering of 11 million shares by existing shareholders at $281.00/share, while simultaneously announcing the company would repurchase 2 million of those shares. The offering closed on June 2, 2026.

Comcast completed the divestiture of Sky Deutschland, with RTL Group confirming the closing of the acquisition on June 1, 2026. The deal had received unconditional approval from the European Commission on April 22, 2026.

CoreWeave announced it is the first AI cloud provider to validate NVIDIA's next-generation Vera Rubin NVL72 platform, leading to a nearly 14% stock rally.

Reported record Q2 2026 earnings, significantly beating analyst estimates with revenue of $10.7B (up 40% YoY) and non-GAAP EPS of $0.79, driven by strong AI server demand. The company also raised its full-year 2026 guidance and now expects to meet its 2028 long-term financial targets in 2026, two years ahead of schedule.

Announced on June 1, 2026, that its Data Center Solutions Business Unit revenue is expected to grow by approximately 65% to around $500 million in calendar year 2026. The stock rose significantly in after-hours trading.

Moderna and Merck to present positive 5-year follow-up data from the Phase 2b study of their personalized cancer vaccine, intismeran autogene, at the 2026 ASCO Annual Meeting on June 1, 2026, showing a 49% reduction in risk; High importance due to the significant 49% reduction in recurrence risk, likely causing ≥10% price impact, scheduled.

Vicki Hollub retired as President and CEO, effective June 1, 2026, and was succeeded by Richard Jackson; this leadership change is estimated to have a high price impact (>10%) due to potential strategic shifts.

U.S. Bancorp announced the completion of its acquisition of BTIG, LLC, effective June 1, 2026, to strengthen its capital markets platform with institutional sales, trading, and investment banking capabilities. High importance assigned as M&A is a significant corporate action (Trading Issue), scheduled.

The European Commission granted marketing authorization for IMDYLLTRA® (tarlatamab) on 2026-06-01 for the treatment of ES-SCLC; expected to have a medium market impact of approximately 5% due to expanded market access.

Biogen and partner UCB announced that their Phase 3 PHOENYCS GO clinical trial for dapirolizumab pegol met its primary endpoint; a 5-10% price impact is estimated as Phase 3 success in a major indication is a significant catalyst, scheduled.

Stock price declined significantly following the launch of a competing equity index futures product by a rival exchange on June 1, 2026, and regulatory approval for competitors' perpetual bitcoin futures, sparking concerns about increased competition.

Estimated Medium importance due to significant contract value; announced a $495 million contract modification from the U.S. Army on 2026-06-01, bringing total value to $3.8 billion, expected.

Uber announced the launch of a robotaxi program in Munich, Germany, in partnership with Autobrains and Nvidia, marking a significant step for its autonomous ride-hailing efforts in Europe.

Announced progress on a production-grade digital twin capability for AI factory infrastructure, integrated with NVIDIA Omniverse DSX Blueprint.

The US FDA accepted the Biologics License Application (BLA) for povetacicept for the treatment of IgA nephropathy (IgAN) on June 1, 2026. This is estimated to have a medium market impact as a significant regulatory milestone. The agency set a PDUFA target action date of November 30, 2026, scheduled.

Announced the expansion of its animal nutrition footprint in Brazil with a new, technologically advanced premix plant in Apucarana. This is expected to have a 1-2% price impact, scheduled.

Citigroup reaffirmed its 'buy' rating on AppLovin stock with a price target of $710.00 forecasted. Low impact estimated as analyst rating reaffirmations generally result in minor market adjustments.

The European Commission approved Opdivo (nivolumab) in combination with AVD on 2026-06-01 for the treatment of Hodgkin Lymphoma; importance is Low as single-indication approvals typically result in a 1-3% price impact.

The U.S. FDA accepted a supplemental New Drug Application for Camzyos on 2026-06-01, granting Priority Review; importance is Low as application acceptance is a procedural milestone with minor price impact.

Morgan Stanley raised its price target on DAL to $105.00 from $90.00 on 2026-06-01, maintaining an overweight rating; >1% price impact forecasted.

Daniel Woodland retired as President of Materials Solutions, effective June 1, 2026, succeeded by Olivier Blachier. Low importance is estimated as it is a planned executive succession.

On 2026-06-01, GE Vernova announced its German nacelle production facility reached a 25 GW cumulative output milestone. This operational success is expected to have a low price impact of at least 1%.

Quarterly dividend of $4.50 per common share with an ex-dividend date of June 1, 2026, and payment on June 29, 2026; positive impact from yield maintenance expected.

The Board of Directors declared a regular quarterly cash dividend of $0.1425 per share, payable around July 15, 2026, to stockholders of record as of June 16, 2026.

Announced the award of several defense contracts in late May totaling over $1 billion, primarily for F-35 aircraft armament equipment. The largest single contract, valued at $879 million, was issued by Naval Air Systems Command on May 18, 2026.

Quarterly dividend of $3.45 per share went ex-dividend on June 1, 2026. The dividend was declared on May 12, 2026 and is payable on June 26, 2026.

Announced on June 1, 2026, plans to implement selective price increases across its product portfolio due to rising input costs, stating it will not affect guidance for the quarter ending June 30, 2026. Low impact is estimated as the company stated this will not affect current quarter guidance.

A French anti-corruption group initiated legal action on 2026-06-01 to compel the bank to provide documents related to its advisory role in the 2022 sale of a Bolloré SE business, alleging potential money laundering. Low importance estimated as legal proceedings are in early stages.

Subsidiary Florida Power & Light Company completed the sale of $2.25 billion in First Mortgage Bonds on June 1, 2026.

The ex-dividend date for NIKE's quarterly cash dividend of $0.41 per share was June 1, 2026. The dividend was declared on May 4, 2026.

Announced a $61 million U.S. Navy contract on June 1, 2026, for electronic warfare aircraft upgrades; a ≥1% price impact is expected.

CEO Cristiano Amon keynote at Computex 2026, outlining the company's AI strategy and introducing the 'Dragonfly' brand, scheduled. Estimated > 1% impact due to new brand introduction.

On June 1, 2026, Charles Schwab redeemed all outstanding shares of its 4.000% Series I Preferred Stock and filed a Certificate of Elimination to simplify its capital structure. This action does not affect common shares. Market impact is estimated to be low as it only affects preferred shares.

Announced positive Phase 3 results for cancer drug Retevmo in early-stage RET fusion-positive non-small cell lung cancer, showing an 83% reduction in the risk of disease recurrence or death; high impact due to breakthrough clinical data expected

U.S. government extended export license rules for advanced AI chips, including AMD's MI350x, to Chinese-owned firms located outside of China, closing a perceived loophole.

Announced the acquisition of homebuilder Taylor Morrison Home Corp. for approximately $6.8 billion in cash on 2026-05-31, with an enterprise value of $8.5 billion. The transaction is expected to close in the second half of 2026. A 5% price impact is expected due to strategic expansion into the homebuilding sector.

Johnson & Johnson announced positive results from the Phase 1b/2 OrigAMI-4 clinical trial for amivantamab in treating advanced head and neck cancer, showing a 42% overall response rate in heavily pretreated patients.

Announced new consumer products at Computex 2026, including the Ryzen 7 7700X3D CPU and the global launch of the Radeon RX 9070 GRE GPU, and extended AM5 platform support through 2029.

Tesla resolved a supply dispute with Syrah Resources on May 31, 2026, by withdrawing a default notice related to a graphite supply agreement. This resolution secures a domestic US source for battery anode material. A low impact is estimated due to supply chain stabilization, scheduled.

Completed a refinancing including a new $1 billion revolving credit agreement and a $250 million term loan facility on 2026-05-31, extending certain debt maturities to 2031 and increasing available liquidity.

Presented positive Phase 3 TALAPRO-3 trial results for the Talzenna and Xtandi combination, showing a 52% reduction in risk of radiographic progression or death in men with a specific type of metastatic prostate cancer.

The U.S. CFTC granted Coinbase permission to offer its U.S. institutional clients access to global cryptocurrency derivatives, including perpetual futures, through its owned platform Deribit, on May 29, 2026. This opens a significant market, as derivatives account for about 80% of global crypto trading volume.

Announced the reduction of 100 daily flights from July 1 to August 7, 2026, due to operational challenges and fuel costs; >10% price impact estimated.

Biogen and Denali announced the discontinuation of BIIB122 for Parkinson's disease on May 29, 2026; a 5-10% price impact is estimated due to the loss of a mid-stage candidate, scheduled.

Scheduled to announce privately-negotiated agreements on 2026-05-29 to exchange approximately $650.4 million of its 0.50% Convertible Senior Notes due 2028 for approximately 5.0 million shares of common stock. Medium importance is estimated as the positive impact of debt reduction is likely offset by share dilution, potentially leading to a 5-10% price impact; scheduled.

Oracle's stock price increased significantly following the announcement of a substantial cloud infrastructure agreement with the US government, positioning the company as a key provider of AI computing capacity for national security.

Multiple analysts raised price targets in late May 2026 following strong earnings, with Susquehanna increasing its target to $3,250 on May 29, 2026, forecasted. Medium importance as target raises typically drive 5-10% price movement.

Announced the launch of SoFiUSD, a bank-issued U.S. dollar stablecoin. The stock reacted positively to the news.

European Commission authorized expanded label for VENCLYXTO (venetoclax) for untreated CLL on 2026-05-29. Low importance as label expansions typically result in moderate price movement.

Amazon continued to reduce its workforce in May 2026 across AWS, Prime Video, and other divisions, following major layoffs earlier in the year, as part of a broader restructuring and efficiency plan.

Announced positive Phase 3 SUCCESSOR-2 trial results for mezigdomide on 2026-05-29, showing a 52% reduction in disease progression risk; importance is Low as clinical trial results usually impact price by 1-4%.

CrowdStrike announced it was named a Leader in the 2026 Gartner® Magic Quadrant™ for Endpoint Protection Platforms for the seventh consecutive time. Low importance is estimated as this recognition is largely anticipated by the market.

Ex-dividend date on 2026-05-29 for a quarterly dividend of $0.14 per share, announced on May 12, 2026. This routine dividend event is estimated to have a low price impact (>=1%), scheduled.

Announced the appointment of Scott A. Keller as the new general counsel on May 29, 2026, effective July 1, 2026, as part of a planned succession for the current chief legal officer who is expected to retire in 2027.

Quarterly dividend of $0.6675 per share, with an ex-dividend date of May 29, 2026. Low importance is estimated as routine dividend announcements typically have minimal price impact, scheduled.

The FDA granted Breakthrough Therapy Designation for the investigational KRAS G12C inhibitor calderasib (MK-1084) on May 29, 2026.

On May 29, 2026, President and CEO Stephen G. Daly sold 15,828 shares under a pre-arranged Rule 10b5-1 trading plan. This routine sale is estimated to have a low impact on stock price.

Scheduled to announce a collaboration with Diakonos Oncology for a Phase I/II clinical trial on 2026-05-29; Low importance due to expected >1% price impact from clinical collaboration scheduled.

Announced seven-year follow-up results from the Phase 3 CROWN trial for LORBRENA, showing an 81% reduction in the risk of disease progression or death in a type of advanced lung cancer.

Announced the acquisition of Tachyus on 2026-05-29, an AI-driven, physics-based modeling software company, to enhance reservoir management and production capabilities.

UPS announced a $50 million investment to enhance logistics for North American manufacturers, including expansion of air freight services to Mexico. Low importance is estimated due to the modest investment size scheduled.

Argus raised its price target on Williams Cos. to $85 from $83 on May 29, 2026, while maintaining a 'Buy' rating, with low impact expected from this minor adjustment, forecasted.

U.S. FDA approved Decnupaz (pivekimab sunirine-pvzy), an ADC acquired via ImmunoGen, for adult BPDCN on 2026-05-28. High importance is estimated as the first ADC for this rare blood cancer, likely driving significant market impact.

A Blue Origin New Glenn rocket, a key launch partner for ASTS, exploded on the launchpad on May 28, 2026, raising concerns about future satellite deployment delays and causing a significant stock price drop.

Axon's stock price surged over 12% on May 28, 2026, attributed to investor confidence following its annual shareholder meeting, a presentation at the TD Cowen TMT conference, and a delayed positive reaction to its strong Q1 earnings report.

CVS Caremark announced it will add Lilly's obesity drugs Foundayo and Zepbound to its preferred formularies, significantly expanding patient access; high impact due to increased market share expected

MongoDB reported Q1 FY2027 earnings, beating revenue and EPS forecasts. Total revenue was $687.6 million, up 25% YoY, and adjusted EPS was $1.32. The company also raised its full-year revenue and earnings guidance. The stock price reacted with high volatility, initially surging over 20% in after-hours trading following the announcement.

Reported strong Q4 and FY2026 earnings, beating estimates with $1.95B revenue and $2.43 EPS, and announced a $1B share repurchase increase.

Activist investor Voss Capital publicly urged Sempra to spin off its Texas-based Oncor electricity business on May 28, 2026, arguing the move would unlock significant shareholder value. High importance is estimated as activist-led spin-off proposals typically drive price volatility exceeding 10%, expected.

The U.S. Surface Transportation Board (STB) accepted the amended merger application from Union Pacific and Norfolk Southern for review on 2026-05-28; high price impact expected due to the significant scale of the proposed transcontinental merger, scheduled.

CrowdStrike announced the expansion of its Project QuiltWorks, adding major cyber insurers like Coalition and Liberty Mutual to address financial exposure to frontier AI risk. Medium importance is estimated due to the strategic entry into AI-related insurance.

Completed the divestiture of its remaining 19% stake in H3C Technologies Co., Limited, receiving cash proceeds of approximately $1.357 billion.

IBM and Red Hat announced Project Lightwell, a $5 billion commitment to help enterprises secure open source software using AI and a global team of over 20,000 engineers.

On May 28, 2026, MACOM completed a strategic investment in IQE plc, acquiring an 11.5% direct stake and additional instruments for a total of 14.7% of voting rights, to secure its supply chain for AI-focused products. This strategic move is estimated to have a medium impact on stock price due to supply chain stability.

RTX, with partner Northrop Grumman, received a DARPA Phase 2 contract to develop modular and composable solid rocket motors to accelerate munitions production.

Tesla was granted authorization by the State of Texas to operate driverless vehicles commercially, effective May 28, 2026. This allows the company to self-certify its autonomous vehicles for commercial robotaxi services under a new state law. A medium impact is estimated as this opens a significant new revenue stream, scheduled.

Axon held its 2026 Annual Meeting of Shareholders on May 28, 2026. Shareholders elected nine directors, approved executive compensation on an advisory basis, and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor.

Costco reported Q3 2026 earnings on May 28, 2026, with net sales of $69.15 billion and EPS of $4.93; the stock fell 4% on May 29, 2026, due to growth concerns.

At the 2026 Annual Meeting of Stockholders on May 28, 2026, the company's stockholders approved an amendment to the 2013 Equity Incentive Plan, increasing the number of shares reserved for issuance by 34 million. Low importance is assigned as this is a routine administrative update with minimal immediate market impact.

The FDA approved a label expansion for TREMFYA® (guselkumab) for the treatment of adults with active psoriatic arthritis, making it the only IL-23 inhibitor with an indication for inhibiting the progression of structural damage.

An FDA advisory committee (VRBPAC) to vote on recommending a monovalent XFG vaccine for the 2026-2027 COVID-19 season on May 28, 2026, a strain for which Moderna has presented positive immunogenicity data; Low importance as advisory committee votes are preliminary and usually result in 1-5% impact, scheduled.

Announced on 2026-05-28 that its antibody maftivimab was recommended by the WHO for clinical trial evaluation; expected to have a low impact as an early-stage development milestone.

S&P Global Ratings upgraded Uber's credit rating to 'BBB+' from 'BBB' with a positive outlook, citing strong cash flow growth and deleveraging.